Expertise in

conditions

Kazuhisa Z. Takahashi

Tokyo, JP

Expertise in

conditions

Tokyo, JP

Overview

Kazuhisa Takahashi practices in Tokyo, Japan. Takahashi is highly rated in 59 conditions, according to our data. Their top areas of expertise are Lymphangioleiomyomatosis, Birt-Hogg-Dube Syndrome, Acute Interstitial Pneumonia, Spinal Fusion, and Osteotomy.

Their clinical research consists of co-authoring 854 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.

Locations

Tokyo, Japan

Other Locations

Bunkyo, Japan

Hongo, 1138421, Japan

Kashiwa, Japan

Yokohama, Japan

Kitano, Japan

Japan

Hirakata, Japan

Osaka, Japan

Okazaki, Japan

Tsukuba, 3058568, Japan

Kyoto, Japan

Tottori, Japan

Nankoku, 7838509, Japan

Itabashi, 1740051, Japan

Chiba, Japan

Hirosaki, Japan

Anjo, Japan

Nagaoka, 9402188, Japan

Kawasaki, 2120013, Japan

Chuo, 2600856, Japan

Chuo, 2608670, Japan

Nagoya, Japan

Koshigaya, Japan

Nagasaki, Japan

Suita, 5650871, Japan

Niigata, Japan

Asahi, 5458585, Japan

Sugimoto, 5588585, Japan

Matsudo, Japan

Otsu, Japan

Izunokuni, 4102295, Japan

Shimonagakubo, 4118777, Japan

Maebashi, Japan

Sagamihara, Japan

Kanagawa, Japan

Towa, Japan

Shinjuku, Japan

Toyama, Japan

Hiroshima, Japan

Meguro, 1538902, Japan

Kanazawa, 9201192, Japan

Toshima, 1718501, Japan

Tochigi, Japan

Murakami, 2608670, Japan

Nigata-honmachi, Japan

Senboku, Japan

Maizuru Fisheries Research Station, Nagahama, Maizuru, 6250086, Japan

Shimotsuke, Japan

Naka, 3110193, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

LIBRETTO-432: A Placebo-controlled Double-Blinded Randomized Phase 3 Study of Adjuvant Selpercatinib Following Definitive Locoregional Treatment in Participants With Stage IB-IIIA RET Fusion-Positive NSCLC

Enrollment Status: Active_not_recruiting

Publish Date: March 04, 2026

Intervention Type: Drug

Study Drug: Selpercatinib

Study Phase: Phase 3

854 Total Publications

Bilateral Chylothorax After 13 Years of Dasatinib Therapy in a Patient With Chronic Myeloid Leukaemia: A Case Report.

Journal: Respirology case reports

Published: January 10, 2026

View All 854 Publications

Frequently Asked Questions about Kazuhisa Z. Takahashi

Is Kazuhisa Z. Takahashi a top-rated expert for Lymphangioleiomyomatosis?

MediFind is an objective health platform that identifies experts based on real-world data. Kazuhisa Z. Takahashi is classified as an Elite expert for Lymphangioleiomyomatosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Kazuhisa Z. Takahashi participate in research or clinical trials?

Yes. Kazuhisa Z. Takahashi has published 854 articles and abstracts on conditions like Lymphangioleiomyomatosis. You can view a list of Kazuhisa Z. Takahashi's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Takahashi's expertise for a condition

ConditionClose